Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Price:
15.49 USD
-2.82%
Market Closed
Updated:
May 20, 2024
Avadel Pharmaceuticals PLC
Cash from Investing Activities
|
Avadel Pharmaceuticals PLC
Cash from Investing Activities Peer Comparison
Comparables:
PRGO
JAZZ
G
GHRS
COPN
OVB
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Investing Activities
-$33.8m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Investing Activities
-$81.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
27%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Investing Activities
-$163.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
16%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Investing Activities
-$54.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Investing Activities
€40.3m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Investing Activities
€1.5m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Avadel Pharmaceuticals PLC's Cash from Investing Activities?
Cash from Investing Activities
-33.8m
USD
-33.8m
USD
Based on the financial report for Mar 31, 2024, Avadel Pharmaceuticals PLC's Cash from Investing Activities amounts to -33.8m USD.
What is Avadel Pharmaceuticals PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-3%
-3%
The average annual Cash from Investing Activities growth rates for Avadel Pharmaceuticals PLC have been 22% over the past three years , and -3% over the past ten years .
You don't have any saved screeners yet
